Vascular disrupting agent  >>  Phase 3
Welcome,         Profile    Billing    Logout  

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials		 036912151821242730
            
            
             
Pexa-Vec (pexastimogene devacirepvec) / SillaJen, Transgene           
          
            
             
Arenegyr (NGR-hTNF) / AGC Biologics           
          
            
             
Zybrestat (fosbretabulin) / Oncotelic           
          
            
             
Tookad (padeliporfin) / ImPact Biotech           
          
            
             
plinabulin (BPI 2358) / BeyondSpring           
          
            
             
ombrabulin (AVE8062) / Sanofi           
          
            
             
ofranergene obadenovec (VB-111) / NanoCarrier, VBL Therap